2015년 2월 18일 수요일

British Journal of Cancer - Table of Contents alert Volume 112 Issue 4


British Journal of Cancer

TABLE OF CONTENTS
Volume 112, Issue 4 (613-776)
Published online 17 February 2015
In this issue
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics


Also new today
Advance online publication
Digital Edition

MINIREVIEW

Top

Actin cytoskeletal control during epithelial to mesenchymal transition: focus on the pancreas and intestinal tract

H T Morris and L M Machesky
Br J Cancer 2015 112: 613-620; advance online publication, January 22, 2015; 10.1038/bjc.2014.658

CLINICAL STUDIES

Top

Evaluation of chemoresponse assays as predictive markers

E L Korn and B Freidlin
Br J Cancer 2015 112: 621-623; advance online publication, January 13, 2015; 10.1038/bjc.2014.661

Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer

T F Hansen, A L Carlsen, N H H Heegaard, F B Sørensen and A Jakobsen
Br J Cancer 2015 112: 624-629; advance online publication, January 13, 2015; 10.1038/bjc.2014.652

Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy

A M Gonzalez-Angulo, N Parinyanitikul, X Lei, E A Mittendorf, H Zhang, V Valero, K K Hunt, G N Hortobagyi and M Chavez-MacGregor
Br J Cancer 2015 112: 630-635; advance online publication, January 13, 2015; 10.1038/bjc.2014.647

The impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapy

E J Bantema-Joppe, G H de Bock, M Woltman-van Iersel, D M Busz, A V Ranchor, J A Langendijk, J H Maduro and E R van den Heuvel
Br J Cancer 2015 112: 636-643; advance online publication, January 20, 2015; 10.1038/bjc.2014.632

Phase I/II study of 131I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma

S G DuBois, S Allen, M Bent, J F Hilton, F Hollinger, R Hawkins, J Courtier, Y P Mosse and K K Matthay
Br J Cancer 2015 112: 644-649; advance online publication, January 20, 2015; 10.1038/bjc.2015.12

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

A Spreafico, J-P Delord, L De Mattos-Arruda, Y Berge, J Rodon, E Cottura, P L Bedard, M Akimov, H Lu, S Pain, A Kaag, L L Siu and J Cortes
Br J Cancer 2015 112: 650-659; advance online publication, January 27, 2015; 10.1038/bjc.2014.653

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

F Trillsch, S Mahner, E Vettorazzi, L Woelber, A Reuss, K Baumann, M-D Keyver-Paik, U Canzler, K Wollschlaeger, D Forner, J Pfisterer, W Schroeder, K Muenstedt, B Richter, C Fotopoulou, B Schmalfeldt, A Burges, N Ewald-Riegler, N de Gregorio, F Hilpert, T Fehm, W Meier, P Hillemanns, L Hanker, A Hasenburg, H-G Strauss, M Hellriegel, P Wimberger, S Kommoss, F Kommoss, S Hauptmann and A du Bois
Br J Cancer 2015 112: 660-666; advance online publication, January 6, 2015; 10.1038/bjc.2014.648

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter

P Giorgi Rossi, C Fortunato, P Barbarino, S Boveri, S Caroli, A Del Mistro, A Ferro, C Giammaria, M Manfredi, T Moretto, A Pasquini, M Sideri, M C Tufi, C Cogo, E Altobelli and the HPV Self-sampling Italian Working Group
Br J Cancer 2015 112: 667-675; advance online publication, January 29, 2015; 10.1038/bjc.2015.11

Impact of investigations in general practice on timeliness of referral for patients subsequently diagnosed with cancer: analysis of national primary care audit data

G P Rubin, C L Saunders, G A Abel, S McPhail, G Lyratzopoulos and R D Neal
Br J Cancer 2015 112: 676-687; advance online publication, January 20, 2015; 10.1038/bjc.2014.634

TRANSLATIONAL THERAPEUTICS

Top

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients

A Laroche-Clary, V Chaire, V Le Morvan, A Neuville, F Bertucci, S Salas, R Sanfilippo, P Pourquier and A Italiano
Br J Cancer 2015 112: 688-692; advance online publication, January 20, 2015; 10.1038/bjc.2014.624

Cell migration in paediatric glioma; characterisation and potential therapeutic targeting

J V Cockle, S Picton, J Levesley, E Ilett, A M Carcaboso, S Short, L P Steel, A Melcher, S E Lawler and A Brüning-Richardson
Br J Cancer 2015 112: 693-703; advance online publication, January 27, 2015; 10.1038/bjc.2015.16

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer

T Watanabe, H Ueno, Y Watabe, N Hiraoka, C Morizane, J Itami, T Okusaka, N Miura, T Kakizaki, T Kakuya, M Kamita, A Tsuchida, Y Nagakawa, H Wilber, T Yamada and K Honda
Br J Cancer 2015 112: 704-713; advance online publication, January 20, 2015; 10.1038/bjc.2014.623

MOLECULAR DIAGNOSTICS

Top

Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells

R G Morgan, E Molnár, R F Jones, T J Collard, J D Lane, A Greenhough, C Paraskeva and A C Williams
Br J Cancer 2015 112: 714-719; advance online publication, January 22, 2015; 10.1038/bjc.2015.4

KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer

S Renaud, B Romain, P-E Falcoz, A Olland, N Santelmo, C Brigand, S Rohr, D Guenot and G Massard
Br J Cancer 2015 112: 720-728; 10.1038/bjc.2014.499

Nuclear osteopontin-c is a prognostic breast cancer marker

K Zduniak, P Ziolkowski, C Ahlin, A Agrawal, S Agrawal, C Blomqvist, M-L Fjällskog and G F Weber
Br J Cancer 2015 112: 729-738; advance online publication, January 27, 2015; 10.1038/bjc.2014.664

High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers

M Miyamoto, M Takano, K Iwaya, N Shinomiya, T Goto, M Kato, A Suzuki, T Aoyama, J Hirata, I Nagaoka, H Tsuda and K Furuya
Br J Cancer 2015 112: 739-744; advance online publication, January 27, 2015; 10.1038/bjc.2015.1

Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation

F Liotta, V Querci, G Mannelli, V Santarlasci, L Maggi, M Capone, M C Rossi, A Mazzoni, L Cosmi, S Romagnani, E Maggi, O Gallo and F Annunziato
Br J Cancer 2015 112: 745-754; advance online publication, February 3, 2015; 10.1038/bjc.2015.15

Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer

V T Baron, R Pio, Z Jia and D Mercola
Br J Cancer 2015 112: 755-764; advance online publication, January 29, 2015; 10.1038/bjc.2014.622

GENETICS AND GENOMICS

Top

Low-level constitutional mosaicism of a de novoBRCA1 gene mutation

E Friedman, N Efrat, L Soussan-Gutman, A Dvir, Y Kaplan, T Ekstein, K Nykamp, M Powers, M Rabideau, J Sorenson and S Topper
Br J Cancer 2015 112: 765-768; advance online publication, January 29, 2015; 10.1038/bjc.2015.14

Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer

B Julin, I Shui, C M Heaphy, C E Joshu, A K Meeker, E Giovannucci, I De Vivo and E A Platz
Br J Cancer 2015 112: 769-776; advance online publication, January 6, 2015; 10.1038/bjc.2014.640

댓글 없음:

댓글 쓰기